Babak Izadi

Babak Izadi

Auto-generated profile, based on publicly available information

Babak Izadi

Molecular Pathology Research Center, Emam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Journal of Controlled Release
Verified
Journal Article
Closed access
HNHoushang Nemati
Houshang Nemati
MGMohammad-Hosein Ghahramani
Mohammad-Hosein Ghahramani
RFReza Faridi-Majidi
Reza Faridi-Majidi
BIBabak Izadi
Babak Izadi
GBGholamreza Bahrami
Gholamreza Bahrami
GTGholamreza Tavoosidana
Gholamreza Tavoosidana

1 September 2017 in New Microbes and New Infections
Verified
Journal Article
Open access
SAS. Atashi
S. Atashi
BIB. Izadi
B. Izadi
SJS. Jalilian
S. Jalilian
SMS.H. Madani
S.H. Madani
AFA. Farahani
A. Farahani
PMP. Mohajeri
P. Mohajeri
Despite a Mycobacterium tuberculosis control programme and anti-tuberculosis drugs, drug-resistant tuberculosis (DR-TB) is one of the most serious public health issues worldwide. Rapid laboratory diagnosis of M. tuberculosis is needed for the diagnosis of multidrug-resistant (MDR) TB and to find the optimal treatment protocol. The purpose of this study was to detect resistance to rifampicin in new cases of TB using the GeneXpert MTB/RIF (M. tuberculosis/rifampicin) assay and the standard proportional method in west and northwest Iran. In this descriptive cross-sectional study, sputum samples were enrolled and screened for M. tuberculosis using Ziehl-Neelsen stain and mycobacterial culture. Samples from individuals with smear-positive TB were cultured on Lowenstein-Jensen medium; afterwards, the presence of resistance to rifampicin was examined by the GeneXpert MTB/RIF and standard proportional methods. A total of 400 new cases of suspected TB were collected, 162 (40.5%) of which were smear- and culture-positive for M. tuberculosis. The frequencies of rifampicin resistance in new smear-positive TB cases were 3.1% and 4.3% for GeneXpert and standard proportional method, respectively. Sensitivity and specificity of GeneXpert were 71% and 100%, respectively, compared with the proportional method. GeneXpert can be a quick and helpful method for the diagnosis of rifampicin-resistant TB in regions with high rates of DR-TB or MDR-TB. GeneXpert MTB-RIF assay must be used as an early diagnostic method whose results must be confirmed by the standard proportional method. The GeneXpert and proportional methods complement but do not replace each other.

1 January 2011 in Indian Journal of Pathology and Microbiology
Verified
Journal Article
Open access
BIBabak Izadi
Babak Izadi
SMSeyedHamid Madani
SeyedHamid Madani
SASomayeh Ameli
Somayeh Ameli
SKSedigheh Khazaei
Sedigheh Khazaei
MKMalek Kanani
Malek Kanani
These proteins expression and compare the obtained results with Gleason's grading. Settings and Design: In this cross-sectional study, 49 paraffin blocks of prostate cancers were assessed. Tumor grade was determined according to the Gleason's criteria. Materials and Methods: Ki-67 and P53 expressions were determined by immunohistochemical staining. Statistical Analysis: The obtained results were analyzed and evaluated using Spearman's statistical test (SPSS version 15). Results: Three out of 49 (6.1%) cases were well differentiated, 21 (43%) moderately differentiated and 25 (51%) were poorly differentiated. P53 was negative in all well-differentiated cases. Ki-67 was negative in 14 cases (28%) including all well-differentiated tumors. Among moderately and poorly differentiated tumors Ki-67 was negative in eight (38%) and three (12%) of cases, respectively. A statistically significant relation was observed between the increased Ki-67 labeling index (LI) and increased Gleason's grade. Conversely, no statistically significant relation was found between P53 expression and increased Gleason's grade. Conclusions: According to the findings of this study, it seems that Ki-67 can be used as a prognostic factor for prostate cancer. On the other hand, the probable relation between P-53 and prostate cancer prognosis requires further studies....

6 February 2017 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
SJSomayeh Jalilian
Somayeh Jalilian
BIBabak Izadi
Babak Izadi
SMSeyed Hamid Madani
Seyed Hamid Madani
PMParviz Mohajeri
Parviz Mohajeri
Background: Human Papillomavirus (HPV) plays a necessary etiological role in cervical cancer, it is logical to use HPV as a marker for the early detection of cervical cancer and precancerous. Prevalence of HPV infection and HPV genotypes vary among different regions. Objectives: The aim of the present study was to investigate the frequency of HPV and its genotype distribution in cervical specimens of the patients who had attended to the pathology laboratories of Kermanshah, Iran. Methods: Cervical swaps, genital, and skin biopsy were obtained from each participant. DNA of HPV specimens were extracted using a genomics extraction kit. PCR amplification and genotyping were employed to investigate the presence of High-risk (HR) and Low-risk (LR) genotypes and also the types of HPV. Results: Human Papillomavirus was found in 62.1% of the samples obtained from the patients. Among the HR and LR types, HPV-6 was the major genotype 64.8%. Type 16 and 18 were the most frequent HR-HPV types (presented in 26% of the patient), followed by type 50s (24.7%), 45, 30s, and 11 (1.8% from each). Multiple HPV infections were presented in 40.7% of the positive genotyping specimens. Conclusions: In comparison with previous surveys done in other parts of Iran, we noticed higher frequency of HPV among the collected isolates and also the higher prevalence of HPV types 6, 16, 18, and 50s in this region of Iran. It seems that HPV vaccination as well as an organized prevention program can be safe and efficient to reduce HPV types. Keywords: Human Papillomavirus; HPV Genotypes; Multiple HPV Infections Prevalence

1 November 2011
Verified
Journal Article
Open access
FNFarid Najafi
Farid Najafi
HMH. R. Mozaffari
H. R. Mozaffari
MKManoochehr Karami
Manoochehr Karami
BIB. Izadi
B. Izadi
RTR. Tavvafzadeh
R. Tavvafzadeh
YPYahya Pasdar
Yahya Pasdar
Background: Few studies have addressed the secular trend of malignancies in developing countries such as Iran. This study aimed to determine the trend in the incidence of gastrointestinal cancers during a period of 15 years in Kermanshah, Iran. Methods: All of the confirmed positive pathologic reports for esophageal, gastric and colorectal cancers from 1993 to 2007 were collected and compared with the data compiled in the provincial health center. The incidence rate was standardized for world population using a direct method. The Fay and Feuer method was used to calculate the 95% confidence intervals for each cancer in each year. Trends were investigated using linear regression. Results: Over the period, 2951 cases of gastrointestinal cancer were reported in Kermanshah Province. The age-standardized incidence rates for gastric, esophageal and colorectal cancers were 9.2, 8.1 and 4.5 per 100,000 respectively over 15 years. In all types, the incidence increased with age. The study showed that the incidence of gastric and esophageal cancers decreased annually by 0.28 (-0.67-0.11) and 0.36 (-0.70 - (-0.02)), respectively. Colorectal cancer demonstrated an increase in the incidence [0.14 (95% CI: -0.01-0.29) annually]. Conclusion: A decrease in the incidence of gastric and esophageal cancers and an increase in the incidence of colorectal cancer are in line with reports from other developing countries in epidemiologic transition. Such trends warrant in depth investigation for the exact reasons.

15 June 2016 in International Journal of Cancer Research
Verified
Journal Article
Closed access
HMHamid Reza Mozaffari
Hamid Reza Mozaffari
BIBabak Izadi
Babak Izadi
Masoud SadeghiMasoud Sadeghi
Masoud Sadeghi
FRFatemeh Rezaei
Fatemeh Rezaei
RSRoohollah Sharifi
Roohollah Sharifi
FJFateme Jalilian
Fateme Jalilian